Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2117/104371

Noninvasive assessment of an engineered bioactive graft in myocardial infarction: impact on cardiac function and scar healing
Gálvez Montón, Carolina; Bragós Bardia, Ramon; Soler Botija, Carolina; Díaz Güemes, Idoia; Prat Vidal, Cristina; Crisóstomo, Verónica; Sánchez Margallo, Francisco M.; Llucia Valldeperes, A.; Bogónez-Franco, Paco; Perea Gil, Isaac; Roura, Santiago; Bayés Genis, Antoni
Universitat Politècnica de Catalunya. Departament d'Enginyeria Electrònica; Universitat Politècnica de Catalunya. IEB - Instrumentació Electrònica i Biomèdica
Cardiac tissue engineering, which combines cells and biomaterials, is promising for limiting the sequelae of myocardial infarction (MI). We assessed myocardial function and scar evolution after implanting an engineered bioactive impedance graft (EBIG) in a swine MI model. The EBIG comprises a scaffold of decellularized human pericardium, green fluorescent protein-labeled porcine adipose tissue-derived progenitor cells (pATPCs), and a customized-design electrical impedance spectroscopy (EIS) monitoring system. Cardiac function was evaluated noninvasively by using magnetic resonance imaging (MRI). Scar healing was evaluated by using the EIS system within the implanted graft. Additionally, infarct size, fibrosis, and inflammation were explored by histopathology. Upon sacrifice 1 month after the intervention, MRI detected a significant improvement in left ventricular ejection fraction (7.5%64.9% vs. 1.4%63.7%; p = .038) and stroke volume (11.565.9 ml vs. 364.5 ml; p = .019) in EBIG-treated animals. Noninvasive EIS data analysis showed differences in both impedance magnitude ratio (20.02 6 0.04 per day vs. 20.48 6 0.07 per day; p = .002) and phase angle slope (20.18°60.24° per day vs.23.52°60.84° per day; p = .004) in EBIG compared with control animals. Moreover, in EBIG-treated animals, the infarct size was 48% smaller (3.4%60.6% vs. 6.5%61%; p = .015), less inflammation was found by means of CD25+ lymphocytes (0.65 6 0.12 vs. 1.26 6 0.2; p = .006), and a lower collagen I/III ratio was detected (0.4960.06 vs. 1.6660.5; p = .019). An EBIG composed of acellular pericardium refilled with pATPCs significantly reduced infarct size and improved cardiac function in a preclinical model of MI. Noninvasive EIS monitoring was useful for tracking differential scar healing in EBIG-treated animals, which was confirmed by less inflammation and altered collagen deposit.
Peer Reviewed
Àrees temàtiques de la UPC::Enginyeria electrònica::Instrumentació i mesura
Àrees temàtiques de la UPC::Ciències de la salut
Biomedical materials
Myocardial infarction
Myocardial infarction
Bioimpedance
Biomedical engineering
Materials biomèdics
Infart de miocardi
Attribution-NonCommercial-NoDerivs 3.0 Spain
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
info:eu-repo/semantics/publishedVersion
Artículo
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Llucia Valldeperes, A.; Soler Botija, Carolina; Gálvez Montón, Carolina; Roura, Santiago; Prat Vidal, Cristina; Perea Gil, Isaac; Sánchez Terrones, Benjamin; Bragós Bardia, Ramon; Vunjak-Novakovic, Gordana; Bayés Genis, Antoni
Llucia Valldeperes, A.; Sanchez, B.; Soler Botija, Carolina; Gálvez Montón, Carolina; Prat Vidal, Cristina; Roura, Santiago; Rosell Ferrer, Francisco Javier; Bragós Bardia, Ramon; Bayés Genis, Antoni
Llucía Valldeperas, Aida; Sánchez Terrones, Benjamin; Soler Botija, Carolina; Gálvez Montón, Carolina; Roura, Santiago; Prat Vidal, Cristina; Perea Gil, Isaac; Rosell Ferrer, Francisco Javier; Bragós Bardia, Ramon; Bayés-Genís, Antoni
Llucía Valldeperas, Aida; Bragós Bardia, Ramon; Soler Botija, Carolina; Roura Ferrer, Santiago; Gálvez Montón, Carolina; Prat Vidal, Cristina; Perea Gil, Isaac; Bayés Genis, Antoni
Prat Vidal, Cristina; Gálvez Montón, Carolina; Sánchez Terrones, Benjamín; Bragós Bardia, Ramon; Bogónez Franco, Francisco; Puig Sanvicens, Verónica